Transfusion and Apheresis Science
Volume 35, Issue 2 , Pages 131-136 , October 2006

A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin

  • Miodrag Palfi

      Affiliations

    • Department of Transfusion Medicine and Clinical Immunology, Faculty of Health Sciences, Linköping University, 581 85 Linköping, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 13 222000; fax: +46 13 223282.
    • ,
  • Jan-Olof Hildén

      Affiliations

    • Department of Transfusion Medicine and Clinical Immunology, Faculty of Health Sciences, Linköping University, 581 85 Linköping, Sweden
    • ,
  • Leif Matthiesen

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Health Sciences, Linköping University, Sweden
    • ,
  • Anders Selbing

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Health Sciences, Linköping University, Sweden
    • ,
  • Gösta Berlin

      Affiliations

    • Department of Transfusion Medicine and Clinical Immunology, Faculty of Health Sciences, Linköping University, 581 85 Linköping, Sweden

Received 19 April 2006 ,Revised 12 July 2006 ,Accepted 13 July 2006.

References 

  1. Bowman JM. Intrauterine transfusion. In:  Anderson KC,  Ness PM editor. Scientific basis of transfusion medicine. Implications for clinical practice. Philadelphia: WB Saunders; 1994;p. 403–420
  2. Berlin G, Selbing A, Ryden G. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet. 1985;1(8438):1153
  3. Fernandez-Jimenez MC, Jimenez-Marco MT, Hernandez D, Gonzalez A, Omenaca F, de la Camara C. Treatment with PE and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang. 2001;80(2):117–120
  4. Haentjens-Verbeke K, Dufour P, Vinatier D, Tordjeman N, Monnier JC, Manessier L. Anti-Tja alloimmunization (anti-PP1Pk): two consecutive pregnancies of an anti-Tja-carrying patient. Fetal Diagn Ther. 1996;11(2):120–125
  5. Berlin G, Selbing A, Gottvall T. Plasma exchange and intravenous immunoglobulin treatment of the mother to diminish fetal Rhesus hemolytic disease. Transf Sci. 1990;11:85–90
  6. Porter TF, Silver RM, Jackson GM, Branch DW, Scott JR. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv. 1997;52(3):193–197
  7. Margulies M, Voto LS, Mathet E, Margulies M. High-dose intravenous IgG for the treatment of severe Rhesus alloimmunization. Vox Sang. 1991;61(3):181–189
  8. Gottvall T, Selbing A. Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus. Acta Obstet Gynecol Scand. 1995;74(10):777–783
  9. Lapierre Y, Rigal D, Adam J, Josef D, Meyer F, Greber S, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion. 1990;30(2):109–113
  10. Hilden JO, Backteman K, Nilsson J, Ernerudh J. Flow-cytometric quantitation of anti-D antibodies. Vox Sang. 1997;72(3):172–176
  11. Palfi M, Hilden JO. Application of the gel test in IgG subclassing – a comparison of two agglutination assays. Vox Sang. 1997;72(2):114–117
  12. Shechter Y, Timor-Tritsch IE, Lewit N, Sela R, Levene C. Early treatment by PE in a woman with multiple abortions and the rare blood group p. Vox Sang. 1987;53(3):135–138
  13. Gravenhorst JB. Management of serious alloimmunization in pregnancy. Vox Sang. 1988;55:1–8
  14. Gottvall T, Hilden JO, Selbing A. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn. Acta Obstet Gynecol Scand. 1994;73(4):300–306
  15. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of Rhesus isoimmunisation. BMJ. 1992;304(6835):1155–1156
  16. Bowman JM. Treatment options for the fetus with alloimmune hemolytic disease. Transf Med Rev. 1990;3:191–207
  17. Palfi M, Selbing A. Placental transport of maternal immunoglobulin G. Am J Reprod Immunol. 1998;39(1):24–26
  18. Grozdea J, Brisson-Lougarre A, Vergnes H, Bierme R, Alie-Daram S, Martin J, et al. IgG/placental alkaline phosphatase complexes in Rh-incompatible pregnancy with fetal hydrops. Vox Sang. 1988;55(1):42–43
  19. Brisson-Lougarre A, Vergnes H, Grozdea J, Alie-Daram S, Fontanilles AM, Bierme R. New antibody in severe rhesus incompatible pregnancies: IgG-kappa antiplacental alkaline phosphatase. Am J Reprod Immunol. 1989;19(4):151–154
  20. Hilden JO, Gottvall T, Lindblom B. HLA phenotypes and severe Rh (D) immunization. Tissue Antigens. 1995;46(4):313–315
  21. Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S. Male fetuses are particularly affected by maternal alloalloimmunization to D antigen. Transfusion. 1999;39(2):169–173
  22. Urbaniak SJ, Duncan JI, Armstrong-Fisher SS, Abramovich DR, Page KR. Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high-dose intravenous immunoglobulin: a possible mechanism of action. Br J Haematol. 1997;96(1):186–193
  23. Clynes R. Immune complexes as therapy for autoimmunity. J Clin Invest. 2005;115(1):25–27
  24. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999;340(3):227–228
  25. Dooren MC, van Kamp IL, Scherpenisse JW, Brand R, Ouwehand WH, Kanhai HH, et al. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox Sang. 1994;66(4):253–257
  26. Nydegger UE, Mohacsi PJ, Escher R, Morell A. Clinical use of intravenous immunoglobulins. Vox Sang. 2000;78(Suppl 2):191–195
  27. Thilaganthan B, Nicolaides KH, Morgan G. Intrauterine bone-marrow transplantation at 12 weeks’ gestation. Lancet. 1993;342(8865):243
  28. Hayward A, Ambruso D, Battaglia F, Donlon T, Eddelman K, Giller R, et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn Ther. 1998;13(1):8–14

PII: S1473-0502(06)00110-8

doi: 10.1016/j.transci.2006.07.002

Transfusion and Apheresis Science
Volume 35, Issue 2 , Pages 131-136 , October 2006

Article Tools